| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 11/03/1992 | CA1309671C Monoclonal antibodies to cyclosporins |
| 10/29/1992 | WO1992018619A1 Heterodimeric receptor libraries using phagemids |
| 10/29/1992 | WO1992018150A1 Mhc conjugates useful in ameliorating autoimmunity |
| 10/29/1992 | WO1992018139A1 Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques |
| 10/29/1992 | WO1992011370A3 Polypeptides derived from proteins of the hepatitis c virus |
| 10/29/1992 | CA2585487A1 Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons |
| 10/28/1992 | EP0511116A1 Antigens recognized by polyarthrits rheumatoid antibodies, preparation and applications |
| 10/28/1992 | EP0510902A1 Immunoassay for detecting group B streptococcus |
| 10/28/1992 | CN1018793B Homologues of aprotinin produced from recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof |
| 10/27/1992 | US5158875 Production of biologically active insulin-like growth factor i from high expression host cell systems |
| 10/21/1992 | EP0509553A1 Anti-lymphotoxin antibody, its production and use |
| 10/21/1992 | EP0509056A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 10/21/1992 | EP0509006A1 Polypeptides selectively reactive with antibodies against human immunodeficiency virus and vaccines comprising the polypeptides |
| 10/21/1992 | CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom |
| 10/20/1992 | US5157112 Antibodies immunoreactive with the T-cell growth factor, P40 |
| 10/20/1992 | US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens |
| 10/20/1992 | CA2064933A1 Carrier protein |
| 10/20/1992 | CA1309041C Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
| 10/19/1992 | WO1992018540A1 Anti-human immunodeficiency virus recombinant antibodies |
| 10/15/1992 | WO1992017201A1 Bradykinin antagonists |
| 10/15/1992 | WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity |
| 10/15/1992 | CA2106677A1 Bradykinin antagonists |
| 10/14/1992 | EP0508809A1 Proteinaceous lipid-containing particles |
| 10/14/1992 | CN1065293A Entomopoxvirus expression system |
| 10/13/1992 | US5155027 Culturing cells having DNA construct encoding a polypeptide having a nonimmuno- and an immunologlobulin chain which dimerize to become biologically active |
| 10/13/1992 | US5154923 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 10/13/1992 | CA1308677C Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis |
| 10/11/1992 | WO1992018621A1 Proteinaceous lipid-containing particles |
| 10/11/1992 | CA2107879A1 Proteinaceous lipid-containing particles |
| 10/10/1992 | WO1992018535A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination |
| 10/10/1992 | CA2081900A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination |
| 10/10/1992 | CA2062675A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination |
| 10/07/1992 | EP0506854A1 An improved toxin for construction of immunotoxins |
| 10/07/1992 | EP0506821A1 Hybrid protein c |
| 10/07/1992 | EP0506815A1 Mucin nucleotides |
| 10/07/1992 | EP0506757A1 A recombinant human factor viii derivative |
| 10/07/1992 | EP0506755A1 Polypeptides having serine protease inhibitor activity and dna coding therefor |
| 10/06/1992 | US5153310 Il-2 analogs containing n-linked glycosylation sites |
| 10/01/1992 | WO1992016621A1 Novel beta integrin subunit |
| 10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/30/1992 | EP0505908A1 Chimaeric polypeptides |
| 09/30/1992 | EP0505846A1 Process for converting fused protein into active type human motilin analogues and purifying the analogues |
| 09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
| 09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
| 09/23/1992 | EP0505151A2 Preparation of the penicilline binding protein 2A from staphylococcus aureus 27R, purification and use in a resistant-assay |
| 09/23/1992 | EP0505148A1 Stimulating factor of the neu receptor |
| 09/23/1992 | EP0504423A1 Method and kit for immunoassay of propeptide of osteocalcin and proosteocalcin |
| 09/23/1992 | EP0504327A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/23/1992 | EP0504257A1 [Ala IL-8] 77 AS A LEUKOCYTE ADHESION INHIBITOR |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | CA1307752C Immunoaffinity purification system |
| 09/20/1992 | CA2063316A1 Dna and amino acid sequence of penicillin binding protein 2a from staphylococcus aureus strain 27r and derivatives for use in purification thereof and assay for compounds effective against methicillin resistant organisms |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/16/1992 | WO1992016845A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0503050A1 Hybrid growth factors |
| 09/16/1992 | EP0502897A1 Endothelial-derived il-8 |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | CA2082929A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016559A1 The trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502099A1 Chimeric proteins |
| 09/09/1992 | EP0180595B1 Method of inhibiting and inducing human platelet aggregation |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/03/1992 | WO1992014815A1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | CA2106099A1 Cultures of permanent lines of human promyelocyte cells and their use for screening molecules useful particularly in treating leukemias |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/01/1992 | US5143844 Construction of an igg binding protein to facilitate downstream processing using protein engineering |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/28/1992 | WO1992015682A1 Serine-rich peptide linkers |
| 08/26/1992 | EP0499837A1 A defined coating of fusion proteins from a constant fusion partner and a variable antigenic part in diagnostic test systems |
| 08/26/1992 | EP0472658A4 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
| 08/25/1992 | CA1306709C Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
| 08/25/1992 | CA1306707C Anti-human pulmonary adenocarcinoma specific monoclonal antibody |
| 08/22/1992 | CA2061574A1 Defined coating with recombinant fusion proteins composed of constant fusion partner and variable antigen portion in diagnostic test systems |
| 08/20/1992 | WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | WO1992013965A1 Method of immobilizing and crosslinking proteins and other molecules and uses thereof |
| 08/20/1992 | WO1992013955A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/20/1992 | WO1992013947A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 08/20/1992 | WO1992013890A1 Nematode vaccine |
| 08/20/1992 | CA2638662A1 Specific peptidic sequences of p. falciparum heptatic stages that carry epitopes capable of stimulating t lymphocytes |
| 08/20/1992 | CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences |
| 08/20/1992 | CA2079871A1 Vaccine |
| 08/19/1992 | EP0499555A1 Recombinant DNA coding for a T-cell receptor chain, process for preparation and antibodies and pharmaceutical compositions comprising the same |
| 08/19/1992 | EP0153961B1 Recombinant materials and methods for producing human connective tissue-activating peptide-iii and analogs thereof |
| 08/18/1992 | US5140103 Quanitative analysis of telopeptides crosslinked by hydroxylysyl pyridinoline(HP) or lysyl pyridinoline(LP) derived from bone collagen reabsorption |